Search hospitals > Missouri > Saint Louis
Missouri Baptist Medical Center
Claim this profileSaint Louis, Missouri 63131
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Breast cancer
Conducts research for Cancer
Conducts research for Non-Small Cell Lung Cancer
383 reported clinical trials
5 medical researchers
Summary
Missouri Baptist Medical Center is a medical facility located in Saint Louis, Missouri. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Cancer, Non-Small Cell Lung Cancer and other specialties. Missouri Baptist Medical Center is involved with conducting 383 clinical trials across 459 conditions. There are 5 research doctors associated with this hospital, such as Bryan A. Faller, James L. Wade, Joshua Baker, MD, and Gus Theodos.Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
Top PIs
Bryan A. FallerCrossroads Cancer Center6 years of reported clinical research
Expert in Lung Cancer
Expert in Breast Cancer
239 reported clinical trials
297 drugs studied
James L. WadeDecatur Memorial Hospital4 years of reported clinical research
Studies Breast Cancer
Studies Bladder Cancer
11 reported clinical trials
20 drugs studied
Joshua Baker, MDCorporal Michael J. Crescenz VA Medical Center, Philadelphia, PA3 years of reported clinical research
Studies Rheumatoid Arthritis
Studies Osteoarthritis
6 reported clinical trials
12 drugs studied
Gus TheodosMissouri Baptist Medical Center4 years of reported clinical research
Studies Coronary Artery Disease
Studies Heart Attack
2 reported clinical trials
2 drugs studied
Clinical Trials running at Missouri Baptist Medical Center
Lung Cancer
Breast Cancer
Pancreatic Cancer
Prostate Cancer
Breast cancer
Colorectal Cancer
Non-Small Cell Lung Cancer
Cancer
Kidney Cancer
Esophageal cancer
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Treatment Timing
for Non-Small Cell Lung Cancer
This phase III trial compares standard therapy given after surgery (adjuvant) to standard therapy given before and after surgery (perioperative) in treating patients with stage II-IIIB non-small cell lung cancer (NSCLC) that can be removed by surgery (resectable). The usual approach for patients with resectable NSCLC is chemotherapy and/or immunotherapy before surgery, after surgery, or both before and after surgery. This study is being done to find out which approach is better at treating patients with lung cancer. Treatment will be administered according to the current standard of care at the time of enrollment. Chemotherapy options may include cisplatin, carboplatin, pemetrexed, gemcitabine, docetaxel, and vinorelbine at standard doses according to the treating physician. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of tumor cells. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Pemetrexed is in a class of medications called antifolate antineoplastic agents. It works by stopping cells from using folic acid to make deoxyribonucleic acid (DNA) and may kill tumor cells. Gemcitabine is a chemotherapy drug that blocks the cells from making DNA and may kill tumor cells. Docetaxel is in a class of medications called taxanes. It stops tumor cells from growing and dividing and may kill them. Other chemotherapy drugs, such as vinorelbine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading . Immunotherapy with monoclonal antibodies, such as nivolumab, pembrolizumab, and atezolizumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Starting treatment with chemotherapy and immunotherapy prior to surgery and continuing treatment after surgery may be a more effective treatment option than adjuvant therapy alone in patients with stage II-IIIB resectable NSCLC.
Recruiting2 awards Phase 34 criteria
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Missouri Baptist Medical Center?
Missouri Baptist Medical Center is a medical facility located in Saint Louis, Missouri. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Cancer, Non-Small Cell Lung Cancer and other specialties. Missouri Baptist Medical Center is involved with conducting 383 clinical trials across 459 conditions. There are 5 research doctors associated with this hospital, such as Bryan A. Faller, James L. Wade, Joshua Baker, MD, and Gus Theodos.
Where is Missouri Baptist Medical Center located?
Missouri Baptist Medical Center is situated at 3015 North Ballas Road, St. Louis, MO 63131. For access, take I-64 West to exit 29A for Ballas Road and then turn right onto North Ballas Road.
Who should I call to ask about financial aid or insurance network?
**Missouri Baptist Medical Center Financial Assistance:**
- For financial assistance, contact (314) 362-8400 or toll-free at (855) 362-8400.
- Visit <https://www.missouribaptist.org/Patient-Visitor-Information> for details on billing and financial assistance policies.
**Washington University Physicians Insurance Inquiries:**
- For insurance-related questions, call the Patient Services line at (314) 273-0500 (option 4) for help with billing and insurance claims.
What insurance does Missouri Baptist Medical Center accept?
Missouri Baptist Medical Center, situated in St. Louis County, accepts a broad range of health insurance plans. For detailed information on accepted insurance plans, please contact the hospital directly at (888) 707-0664.
What awards or recognition has Missouri Baptist Medical Center received?
Missouri Baptist Medical Center, located in St. Louis, Missouri, is nationally recognized for its advancements in stroke treatment. It ranks among the top hospitals in both the St. Louis metro area and Missouri, as per U.S. News & World Report. The center is also celebrated for its dedication to nursing excellence and delivering quality patient care.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.